Publications by authors named "C K Ayata"

Rho-associated protein kinase (ROCK) inhibitors are therapeutic candidates in ischemic stroke and subarachnoid hemorrhage. However, their efficacy in intracerebral hemorrhage (ICH) is unknown. Here, we tested the efficacy of fasudil (10 mg/kg), an isoform-nonselective ROCK inhibitor, and NRL-1049 (10 mg/kg), a novel inhibitor with 43-fold higher selectivity for ROCK2 isoform compared with ROCK1, in a collagenase-induced ICH model in mice.

View Article and Find Full Text PDF

It remains unclear why unilateral proximal carotid artery occlusion (UCAO) causes benign oligemia in mice, yet leads to various outcomes (asymptomatic-to-death) in humans. We hypothesized that inhibition of nitric oxide synthase (NOS) both transforms UCAO-mediated oligemia into full infarction and expands pre-existing infarction. Using 900 mice, we i) investigated stroke-related effects of UCAO with/without intraperitoneal administration of the NOS inhibitor (NOSi) N-nitro-L-arginine methyl ester (L-NAME, 400 mg/kg); ii) examined the rescue effect of the NO-donor, molsidomine (200 mg/kg at 30 minutes); and iii) tested the impact of antiplatelet medications.

View Article and Find Full Text PDF

Spreading depolarization (SD) develops after stroke and traumatic brain injury and may contribute to secondary brain damage. These diseases are often accompanied by intracranial hypertension, but little is known about the effects of intracranial pressure (ICP) on SD. Here, we study the effect of increased ICP on hemodynamic and metabolic response to SD in rats.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of cortical spreading depolarization (SD) in triggering migraine-related pain by focusing on a specific brain region, the paraventricular nucleus (PVN), and its connection to oxytocin signaling.* -
  • Using a genetically modified mouse model, researchers found that opto-SD significantly increased markers of neuronal activity in the PVN, indicating that this area is activated during migraine-like pain responses.* -
  • Treatment with an oxytocin receptor antagonist reduced pain behavior induced by opto-SD, suggesting that oxytocin plays a role in modulating trigeminal pain linked to migraines.*
View Article and Find Full Text PDF